Innovation uptake has played a significant role in strengthening response to HIV globally. Some of these innovations are newly developed and others a modification of existing technologies. The goal is to share information on the technological innovations that have already made a difference in other parts of the World for Adaptation and scaling in the African region.

Centers for Disease Control and Prevention Website

Centers for Disease Control and Prevention Website

Centers for Disease Control and Prevention
United states of America
Medscape HIV/AIDS

Medscape HIV/AIDS

Medscape
United states of America
MP Diagnostics HIV Blot 2.2

MP Diagnostics HIV Blot 2.2

MP Biomedicals Asia Pacific, Singapore
Singapore
NEW LAV BLOT I

NEW LAV BLOT I

Bio-Rad Laboratories Steenvoorde
France
NEW LAV BLOT II

NEW LAV BLOT II

Bio-Rad Laboratories Steenvoorde
France
Abbott PRISM HIV Ag/Ab Combo Assa

Abbott PRISM HIV Ag/Ab Combo Assa

Abbott Diagnostics, Wiesbaden, Germany
Germany
AiD anti-HIV 1+2 ELISA

AiD anti-HIV 1+2 ELISA

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Enzygnost HIV Integral 4
and Supplementary reagents kit for
Enzygnost®/TMB

Enzygnost HIV Integral 4 and Supplementary reagents kit for Enzygnost®/TMB

Siemens Healthcare Diagnostics Products GmbH Marburg, Germany
Germany
GenScreen™ HIV 1/2 Version 2

GenScreen™ HIV 1/2 Version 2

Bio-Rad Laboratories, Marnes La Coquette, France and Bio-Rad Laboratories, Steenvoorde, France
France
GenScreen™ ULTRA HIV Ag-Ab

GenScreen™ ULTRA HIV Ag-Ab

Bio-Rad Laboratories, Steenvoorde, France
France
HIV 1&2 Ab, cut-off

HIV 1&2 Ab, cut-off

Dialab GmbH, Austria
Austria
LIAISON XL

LIAISON XL

DiaSorin S.p.A., Saluggia (Vercelli), Italy
Italy